ScreenerHero

RHK RHÖN-KLINIKUM Aktiengesellschaft

XETRA · DE · Healthcare · Medical Care Facilities · rhoen-klinikum-ag.com
14.40EUR0.00%Mkt Cap: 1.05B $P/E: 22.50

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabili…

Industry Peers

Medical Care Facilities
Screen all
HCA
HCA Healthcare, Inc. Common Stock
$94.66BUSDP/E 14.3
FRE
Fresenius SE & Co. KGaA
$26.85BUSDP/E 15.8
THC
Tenet Healthcare Corporation Common Stock
$20.82BUSDP/E 10.0
FME
Fresenius Medical Care AG
$11.75BUSDP/E 12.1
FMS
Fresenius Medical Care AG American Depositary Shares (Each representing 1/2 of an Ordinary Share)
$11.84BUSDP/E 11.8
EHC
Encompass Health Corporation Common Stock
$11.82BUSDP/E 20.0
DVA
DaVita Inc. Common Stock
$11.47BUSDP/E 15.1
UHS
Universal Health Services, Inc. Common Stock
$10.36BUSDP/E 7.2
ENSG
The Ensign Group, Inc. - Common Stock
$10.01BUSDP/E 26.9
PACS
PACS Group, Inc. Common Stock
$6.78BUSDP/E 25.1
CHE
Chemed Corp
$6.63BUSDP/E 25.5
CON
Concentra Group Holdings Parent, Inc. Common Stock
$4.55BUSDP/E 23.0
LFST
LifeStance Health Group, Inc. - Common Stock
$4.50BUSDP/E 91.0
MCOV-B
Medicover AB (publ)
$3.77BUSDP/E 42.5
NHC
National HealthCare Corporation Common Stock
$3.57BUSDP/E 25.6
OPCH
Option Care Health, Inc. - Common Stock
$3.39BUSDP/E 17.2
AVAH
Aveanna Healthcare Holdings Inc. - Common Stock
$2.75BUSDP/E 10.0
GRDN
Guardian Pharmacy Services, Inc. Class A Common Stock
$2.68BUSDP/E 40.8
ACHC
Acadia Healthcare Company, Inc. - Common Stock
$2.61BUSD
BKD
Brookdale Senior Living Inc. Common Stock
$2.59BUSD

Key Statistics

Company
Market Cap1.05B USD
Enterprise Value873.30M USD
Revenue (TTM)2.20B USD
Gross Profit209.55M USD
Net Income (TTM)37.47M USD
Revenue/Share30.29 EUR
Last Price14.40 EUR
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees19.1K
CountryDE
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)22.50
P/E (Forward)18.23
PEG4.01
EV/EBITDA7.20
EV/Revenue0.40
P/S0.48
P/B0.73
EPS (TTM)0.64
EPS (Forward)0.79
52W Range
11.3070% of range15.70
52W High15.70 EUR
52W Low11.30 EUR
Profitability
Gross Margin11.31%
Oper. Margin2.35%
EBITDA Margin5.51%
Profit Margin2.02%
ROE2.61%
ROA1.89%
Growth
Revenue Growth5.00%
Earnings Growth40.00%
Cash Flow & Leverage
Operating CF62.17M USD
CapEx (TTM)107.72M USD
FCF Margin-3.11%
FCF Yield-6.55%
Net Debt-207.50M USD
Net Debt/EBITDA-1.71
Balance Sheet
Debt/Equity0.09
Current Ratio2.63
Quick Ratio2.36
Book Value/Sh19.86 EUR
Cash/Share4.67 EUR
Dividends
Fwd Div Rate0.20 EUR
Trail. Div Rate0.20 EUR
Div. Yield1.39%
5Y Avg Yield1.34%
Payout Ratio31.25%
Ex-Div DateMay 28, 2026
Pay Date—
Splits
Last Split2:1
Split DateJul 13, 2007
Analyst Consensus
Rating—
Target (Mean)12.50 EUR
Upside (mean)-13.2%
Target Range12.50 EUR – 12.50 EUR
# Analysts1
Ownership
Shares Out.66.94M
Float3.65M
Insiders0.00%
Institutions0.51%
Technical
SMA 5014.27 (+0.9%)
SMA 20013.16 (+9.4%)
Beta0.01
S&P 52W Chg14.58%
Avg Vol (30d)3.94K
Avg Vol (10d)9.86K
Technical Indicators
RSI (14)50.3
MACD0.0345
MACD Signal0.0459
MACD Hist.-0.0115
BB Upper14.69 EUR
BB Middle14.45 EUR
BB Lower14.20 EUR
BB Width3.42%
ATR (14)0.2745 EUR
Vol Ratio (20d)0.06x